Thomas H. Tulip

2012

In 2012, Thomas H. Tulip earned a total compensation of $713.4K as President and Chief Business Officer at Navidea Biopharmaceuticals, a 27% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$75,075
Option Awards$314,151
Salary$314,583
Other$9,615
Total$713,424

Tulip received $314.6K in salary, accounting for 44% of the total pay in 2012.

Tulip also received $75.1K in non-equity incentive plan, $314.2K in option awards and $9.6K in other compensation.

Rankings

In 2012, Thomas H. Tulip's compensation ranked 7,490th out of 11,487 executives tracked by ExecPay. In other words, Tulip earned more than 34.8% of executives.

ClassificationRankingPercentile
All
7,490
out of 11,487
35th
Division
Manufacturing
2,693
out of 4,253
37th
Major group
Chemicals And Allied Products
695
out of 1,198
42nd
Industry group
Drugs
484
out of 920
47th
Industry
In Vitro and In Vivo Diagnostic Substances
22
out of 47
53rd
Source: SEC filing on June 5, 2015.

Tulip's colleagues

We found four more compensation records of executives who worked with Thomas H. Tulip at Navidea Biopharmaceuticals in 2012.

2012

Mark Pykett

Navidea Biopharmaceuticals

Chief Executive Officer

2012

Frederick Cope

Navidea Biopharmaceuticals

Chief Scientific Officer

2012

Brent Larson

Navidea Biopharmaceuticals

Chief Financial Officer

2012

Rodger Brown

Navidea Biopharmaceuticals

Vice President, Global Regulatory Operations and Quality Assurance

You may also like